The loss of SMARCA4 is associated with the development of advanced dedifferentiated tumors and an increased incidence of tumor metastasis (7).The SMARCA4 gene encodes the BRG1 protein, and its loss is associated with a poor prognosis. This evidence concerns the gene SMARCA4 and neoplasm.